Interleukin-1beta increases elasticity of human bioartificial tendons

Area of Science:

• Biomaterials Science
• Tissue Engineering
• Cell Biology

Background:

• Connective tissue stiffness is crucial, especially for tendons under cyclic strain.
• Modulating tissue material properties is key for effective tissue repair.
• Interleukin 1-beta (IL-1beta) is typically linked to matrix degradation but may also promote constructive remodeling and cell survival.

Purpose of the Study:

• To investigate the effects of IL-1beta on the mechanical properties of human tenocyte-populated bioartificial tendons (BATs).
• To explore the role of IL-1beta in matrix remodeling and cell survival in engineered tendon constructs.

Main Methods:

• Fabrication of human tenocyte-populated bioartificial tendons (BATs) using a novel 3D culture system.
• Treatment of BATs with varying doses of IL-1beta.
• Assessment of mechanical properties (ultimate tensile strength, elastic modulus, maximum strain) and gene expression (elastin, type I collagen, matrix metalloproteinases).

Main Results:

• IL-1beta treatment decreased ultimate tensile strength and elastic modulus while increasing maximum strain in BATs.
• Low doses of IL-1beta upregulated elastin expression; high doses downregulated type I collagen expression.
• Matrix metalloproteinases were upregulated by IL-1beta, and increased elasticity protected BATs from rupture.

Conclusions:

• IL-1beta may function as a defense/survival factor for tenocytes in response to mechanical loading.
• The interplay between intrinsic cell strain and external matrix strain is vital for tendon integrity.
• Findings suggest a potential therapeutic role for IL-1beta in tendon repair and tissue engineering.